Doxorubicin Market Size, Share 2019 | Global Industry Overview, Demand, Insights, New Developments, Top Company Profile, Key Regions forecast to 2023
May 8, 2019
“The Latest Research Report Global Doxorubicin Market By 2023 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”
Pune, India - May 8, 2019 /MarketersMedia/ —
Market Analysis
The global doxorubicin market is projected to have a steady growth rate at a whopping 6.5% CAGR over the forecast period (2016-2023). Doxorubicin or anthracycline is a form of chemotherapy medicine that is used for diminishing or reducing growth of cancer cells via blocking the topo isomerase enzyme. This drug is utilized alone or together with other drugs for treating various types of cancers such as ovarian, stomach, bladder, lung, breast, non-Hodgkin and Hodgkin lymphomas, neuroblastoma and specific forms of leukemia. The treatment rests upon the cancer type being treated, how well a patient responds to the medicine and other forms of drugs that the patient takes at the time of the treatment. Doxorubicin comes in both lyophilized power form and injection solution. It is generally administered intravenously through central venous catheters (CVC) or peripheral inserted central line catheters (PICC).
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7376
There are abundant factors that is propelling the growth of the doxorubicin market. These factors as per the MRFR (Market Research Future) report include increasing prevalence of various forms of cancer, boost in geriatric population, growing awareness of cancer treatment and inclusion of the drug in different applications such as AIDS-related Kaposi Sarcoma and neuroblastoma, growing cancer treatment awareness programs, large presence of ablation and surgical centers and technological advancements. On the contrary stringent regulatory authorities, various cost suppression measures undertaken by different governments and numerous side effects resulting from doxorubicin are factors that are likely to hamper the growth of the doxorubicin market. Some of the common side effects of taking doxorubicin include inflammation of the mouth, rash, vomiting, bone marrow suppression, hair loss, allergic reactions namely anaphylaxis, damage of tissue owing to the position of the injection, heart damage, treatment associated to leukemia and radiation recall. All these side effects and more are affecting the doxorubicin market growth.
Key Players
Leading players profiled in the doxorubicin market include -
GLENMARK PHARMACEUTICALS LTD
Teva Pharmaceuticals
Dr. Reddy’s Laboratories Ltd.
Sandoz
Novartis AG
Accord Healthcare
Janssen Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Pfizer Inc
Market Segmentation
MRFR report offers a broad segmental analysis of the doxorubicin market on the basis of application and distribution channel.
Based on application, the doxorubicin market is segmented into leukemia, ovarian cancer, stomach cancer, prostate cancer, bone sarcoma, breast cancer, gastric cancer, liver cancer and others. Of these, prostate and breast cancer will have the largest share in the market over the forecast period.
Based on distribution channel, the doxorubicin market is segmented into retail pharmacy, hospital pharmacy and others. Of these, hospital pharmacy is projected to lead the market over the forecast period.
Regional Analysis
By region, the Doxorubicin Market covers growth opportunities and latest trends across Americas, the Middle East and Africa, Europe and Asia Pacific. Of these, the Americas will remain the vital contributor in the market over the forecast period. Factors attributed for the market growth in this region include favorable regulatory authorities and reimbursement, awareness about cancer treatment, increase in cancer cases and presence of leading manufacturers. The doxorubicin market in Europe will account for the second major share owing to rising healthcare expenditure and increasing pool of cancer patients. In the APAC region, the doxorubicin market is projected to grow at the fastest pace over the forecast period. This is on account of growing geriatric population especially in China and India, growing number of manufacturers looking for opportunities in developing countries, government investment and initiatives for the healthcare sector development and increasing cancer treatment awareness programs. On the other hand, the doxorubicin market in the Middle East and Africa is prognosticated to have minimal share over the forecast period.
Industry News:
March 2019 - SourcingLink.net, Inc. (SNET) has lately revealed the news of entering into a worldwide exclusive licensing agreement with leading biopharmaceutical company, NanoSmart Pharmaceuticals, Inc. This agreement has been made for the right of utilizing nanoparticle platform technologies of NanoSmart for developing and commercializing doxorubicin’s improved formulations to treat human cancers. It will impact countless cancer patients all across the world and also offer the increasing global cancer population with enhanced therapy options, including patients with unmet rare cancer needs.
Related Reports:
Global Connected Medical Devices Market Research Report - Forecast to 2027
Vascular Closure Devices Market Research Report - Forecast to 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com
Source: MarketersMedia
Release ID: 510292
More News
I Gave My Life Over to Meta’s A.I. Agent and Was Blown Away
Muse, Meta’s A.I. agent, helped handle my dental insurance, booked dinner reservations and created a podcast for me. It also required my most personal data, and trust.
Texas Halts Data Center Permits, Expanding Environmental Scrutiny
Less than a year ago, Gov. Greg Abbott welcomed data centers. Now he is confronting concerns about the projects even among fellow Republicans.
An Army of Paid Creators Is Carpeting the Web With Political Content
Unlike celebrity influencers with large followings, these creators produce a blizzard of videos for a fraction of the cost of traditional online campaigns and, in the process, shift public conversation.
An A.I. Image of Trump Kissing a Woman Was Fake. It Spread Anyway.
Advances in artificial intelligence and the myriad ways content is shared online have made establishing authenticity even more difficult for users of social media.
Check Point Warns of Management Server Zero-Day Exploited in Targeted Attacks
Attackers exploited a previously unknown flaw in Check Point's Security Management Server in a handful of targeted attacks on July 23, the company said. The flaw, CVE-2026-93616, allows an attacker who can access the server's web service to run scripts on it without logging in. Check Point released a fix on September 22 for the server that controls firewall policies for the Check Point
$345 Million Verdict Against Greenpeace Should Be Overturned, Lawyers Say
A group of civil-rights and free-speech lawyers accused the judge of bias and “general incompetence.”
Anthropic Releases a New A.I. Model, Opus 5.5, Amid Safety Debate
The company released a cheaper, faster model that it said was the strongest performer on its most rigorous internal safety tests to date.
WordPress Issues Patch for Critical Flaw That Can Enable Code Execution on Some Servers
WordPress has fixed a critical flaw in its core software that lets an attacker with no account make a site load a PHP file from outside its theme folders. On some servers, that can go further, allowing the attacker to run their own code. The fix shipped on September 22 in WordPress 7.1.2, with fixes for every branch the project still supports, back to 4.7, and WordPress is telling site owners
Malicious npm Package Poses as Twilio Bug-Bounty Probe, Can Exfiltrate Credentials
Cybersecurity researchers have disclosed details of a malicious npm package named "tw-pkgprobe-7731" that masquerades as a security tool targeting developers integrating Twilio into their applications, while stealthily attempting to harvest sensitive data. The package, named "tw-pkgprobe-7731," was first uploaded to the npm registry in mid-August 2026 by an npm account named "twdepprobe7731."
Microsoft Takes Down EvilTokens Device-Code Phishing Service Tied to 12,000 Inbox Compromises
Microsoft on Tuesday announced the takedown of the EvilTokens device code phishing service that it said used artificial intelligence (AI) "at every step of the attack chain." The action, carried out with authorization from the U.S. District Court for the Eastern District of Virginia, involved the efforts of Health-ISAC, alongside Cloudflare, Coinbase, OpenAI, Railway, SpyCloud, The Shadowserver
Critical Bifrost AI Gateway Flaw Lets Attackers Run Commands Without Credentials
A critical vulnerability in Bifrost, an open-source AI gateway that routes requests to more than 20 LLM providers, allows an unauthenticated attacker to run arbitrary commands on the gateway server with a single HTTP request. The flaw, tracked as CVE-2026-90898 (CVSS score: 9.8), affects all versions of the Bifrost HTTP transport before 2.1.0 when management authentication is
The Big Threat Has Been Climate Change. Now Comes A.I.
Both are human-caused, both are frightening, and one of them has raced to the forefront of the global conversation.
Recommended
Tech Life
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.